Carl F. Mauch
Investor Relations Contact chez TCR2 THERAPEUTICS INC.
Profil
Carl F.
Mauch currently works at Stern Investor Relations, Inc., as Director from 2016, TCR2 Therapeutics, Inc., as Investor Relations & Media Contact, and iTeos Therapeutics, Inc., as Investor Relations & Media Contact.
Postes actifs de Carl F. Mauch
| Sociétés | Poste | Début |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Investor Relations Contact | - |
| ITEOS THERAPEUTICS, INC. | Investor Relations Contact | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Director/Board Member | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
